Virbac (XPAR:VIRP) ROCE % : 22.87% (As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Virbac ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Virbac's annualized ROCE % for the quarter that ended in Jun. 2023 was 22.87%.

Virbac ROCE % Historical Data

The historical data trend for Virbac's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac ROCE % Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

6.21

10.09

21.05

20.27

20.31

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial															25.49	14.61	24.13	14.82	22.87

Virbac ROCE % Calculation

Virbac's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	180.134	/	( ( (1201.551 - 370.751)	+	(1333.511 - 390.586) )	/ 2 )
	=	180.134	/	( (830.8	+	942.925)	/ 2 )
	=	180.134	/	886.8625
	=	20.31 %

Virbac's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	227.11	/	( ( (1333.511 - 390.586)	+	(1420.614 - 377.272) )	/ 2 )
	=	227.11	/	( ( 942.925	+	1043.342 )	/ 2 )
	=	227.11	/	993.1335
	=	22.87 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Virbac (XPAR:VIRP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Virbac ROCE % Related Terms

Thank you for viewing the detailed overview of Virbac's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (XPAR:VIRP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0NM7:UK V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (XPAR:VIRP) Headlines

No Headlines